These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8849227

  • 1. Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.
    Goldman RC, Zakula D, Capobianco JO, Sharpe BA, Griffin JH.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1044-7. PubMed ID: 8849227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase.
    Rabelo VW, Viegas DJ, Tucci EMN, Romeiro NC, Abreu PA.
    J Steroid Biochem Mol Biol; 2019 Jan; 185():189-199. PubMed ID: 30193921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pyridines and pyrimidines mediating activity against an efflux-negative strain of Candida albicans through putative inhibition of lanosterol demethylase.
    Buurman ET, Blodgett AE, Hull KG, Carcanague D.
    Antimicrob Agents Chemother; 2004 Jan; 48(1):313-8. PubMed ID: 14693556
    [Abstract] [Full Text] [Related]

  • 9. Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2,3-epoxy-10-aza-10,11-dihydrosqualene.
    Balliano G, Milla P, Ceruti M, Viola F, Carrano L, Cattel L.
    FEBS Lett; 1993 Apr 12; 320(3):203-6. PubMed ID: 8462686
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells.
    Mark M, Muller P, Maier R, Eisele B.
    J Lipid Res; 1996 Jan 12; 37(1):148-58. PubMed ID: 8820110
    [Abstract] [Full Text] [Related]

  • 14. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H, Belanger P, Fratti R, Ghannoum M.
    Antimicrob Agents Chemother; 1997 Nov 12; 41(11):2492-6. PubMed ID: 9371355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.
    Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, Schumacher U, Einsele H.
    FEBS Lett; 1997 Jan 02; 400(1):80-2. PubMed ID: 9000517
    [Abstract] [Full Text] [Related]

  • 18. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
    Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA.
    Antimicrob Agents Chemother; 1997 Jun 02; 41(6):1392-5. PubMed ID: 9174207
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA, Lone SA, Gull P, Dar OA, Wani MY, Ahmad A, Hashmi AA.
    Med Chem; 2019 Jun 02; 15(6):648-658. PubMed ID: 30501599
    [Abstract] [Full Text] [Related]

  • 20. The combination effects of phenolic compounds and fluconazole on the formation of ergosterol in Candida albicans determined by high-performance liquid chromatography/tandem mass spectrometry.
    Sun S, Gao Y, Ling X, Lou H.
    Anal Biochem; 2005 Jan 01; 336(1):39-45. PubMed ID: 15582556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.